By selling subsidiaries, the mid-term net profit of the rainbow Holding is 5 times times greater

After deducting the non-recurrent profit and loss, the net profit loss is 52.9346 million yuan; it will take no more than 300 million of its own funds to invest in securities Liu Baoqiang August 24, the Sea Rainbow Holding (000503.SZ) issued a report, mainly because of the company to sell shares of subsidiaries to obtain higher investment income, The company achieved a net profit of 19.3679 million yuan in the first half of the year, a large increase of 555.92%, but the net profit after the Non-recurrent gain is 52.9346 million yuan.　　Company announcement on the same day, will be not more than 300 million yuan (accounting for the company 2010 Annual audit of the net assets of 23.43%) own funds investment securities. During the reporting period, the company realized operating income of 54.4529 million yuan, down 36.96% from the same period last year. The company said that the main reason is because of changes in national policy, pharmaceutical electronic transactions and E-commerce business in the adjustment period, the drug tender and service items appear a significant decline.　　During the reporting period, the company's main business of pharmaceutical E-commerce and transactions to achieve business income of 52.0754 million yuan, gross profit margin of 51.24%, the year-on-year growth of 14.03% and reduce 21.8%. In the joint venture, the company said that in order to make more effective use of the company's existing platform and local resource advantages, to accelerate the localization process to achieve significant market share and sustained profit growth, July 12, 2011, the company and the United States ESI Group signed a joint venture equity restructuring shareholder Agreement, After the reorganization, the company has a 51% stake in the joint venture, and the US has 49%. Joint venture after more than a year of preliminary research and other preparations, has begun in some provinces and cities to negotiate business landing.　　The company and the General Technology Group Pharmaceutical Holdings Limited set up a joint venture, in the process of changing the name of the company and increase the relevant business scope, such as business change procedures, has been in some provinces and cities to carry out business research and negotiation work. It is because of the main industry's lack of power, coupled with the joint venture has not yet produced significant benefits, the sale of subsidiary stock and Investment securities has become a major source of revenue. In the first half of the year, Wei Devofu acquisition Company holds the remaining 13.3% stake in the computer, the acquisition price of 21.28 million yuan, and Wei Devofu acquisition Company held OAL remaining 13.3% stake, the acquisition price of RMB 48.97 million yuan.　　and the securities investment, also has certain income. may have tasted the sweetness of the securities investment, the company said, with the development of securities market norms, the value of the investment in the securities market is increasingly apparent. The investment business of the securities market is less risky and the income is relatively stable. In order to broaden the company's investment channels, improve the efficiency of the company and the company's foreign subsidiaries, enhance the profitability of the company, without affecting the normal operation of the company and its controlling subsidiaries, the company will use some of its subsidiaries for securities investment.　　The investment mode includes the new stock placing, the purchase, the stock repurchase, the stock and so on two level market investment, the bond investment, the entrust financing (including the Bank Wealth Management product, the trust product) carries on the securities investment as well as the Shenzhen Stock Exchange identified other investment behavior. A brokerage analyst said the Sea RainbowHolding is a more "fashionable" company, what business is fashionable, the company engaged in what business. Compared to a few years ago, the company is now in the pharmaceutical e-commerce more stable, the company took no more than 300 million yuan capital for the securities market investment. This on the one hand shows that the company lacks new business growth point, on the other hand, it also shows that companies are familiar with the securities market, because the market is also a rare low valuation, low risk of time. CFP Map